VISMED® Light
Product Description
TRB Chemedica International SA
-
Country/Region:Switzerland
-
On CPHI since:2016
-
Certificates:2
-
Employees:500 - 999
Company types
Categories
Specifications
TRB Chemedica International SA
-
Country/Region:Switzerland
-
On CPHI since:2016
-
Certificates:2
-
Employees:500 - 999
Company types
More Products from TRB Chemedica International SA (10)
-
Product OSTENIL® Tendon
OSTENIL® TENDON was developed to treat pain and restricted mobility in tendon disorders. It is a conservative treatment based on the biomechanical properties of hyaluronic acid.
OSTENIL® TENDON is injected into the tendon sheath (intrasheath injection) or around the affected tendon (peritendinous i... -
Product REMOGEN® Omega
REMOGEN® OMEGA is indicated in case of ocular surface damage such as irritation, redness, burning, pain, dry eye, ocular fatigue and foreign body sensation.
REMOGEN® OMEGA is an innovative patented preservative-free eye drop formulation of topical Omega-3 polyunsaturated fatty acids... -
Product VISCOSEAL® syringe
VISCOSEAL® is a viscoelastic solution containing hyaluronic acid. This solution has viscoelastic properties that are very close to those of normal synovial fluid.
VISCOSEAL® is indicated as a synovial fluid replacement after arthroscopy. In clinical trials, it has been shown to relieve p... -
Product VISMED®
VISMED® is a unique preservative-free lubricant eye drop that offers an unmatched combination of long-lasting relief of sensations of ocular dryness with optimal eye comfort.
VISMED® is compatible with all types of contact lenses (rigid or soft) during wear.
VISMED® is... -
Product VISMED® Gel
VISMED® GEL is a preservative-free viscoelastic solution for sustained lubrication of the eyes in case of sensations of dryness, burning or ocular fatigue induced by environmental conditions, extended computer screen use, contact lens wear or by ophthalmological screening methods.
VISMED® GE... -
Product VISMED® Gel Multi
VISMED® GEL is a patented hypotonic formulation that contains both 0.30% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, and most of the essential ions that are present in natural tears.
VISMED® GEL MULTI is indicated in case of sy... -
Product VISMED® Multi
VISMED® MULTI is a unique lubricant eye drop in an innovative preservative-free, multidose system. VISMED® multi offers an unmatched combination of long-lasting relief of sensations of ocular dryness and optimal eye comfort.
VISMED® MULTI is a patented hypotonic formulation that contains both 0... -
Product OSTENIL®
OSTENIL® is a solution containing hyaluronic acid for injection into the joint cavity.
OSTENIL® is indicated for the treatment of symptoms of osteoarthritis. It has been shown to reduce pain and stiffness in the affected joint and to improve joint function
Pre-filled syringe to relieve pain in... -
Product OSTENIL® mini
OSTENIL® mini is indicated for the treatment of symptoms of osteoarthritis in small synovial joints such as the carpometacarpal joint of the hand, the ankle joint, the temporomandibular joint and the facet joint of the spine. OSTENIL® MINI: pre-filled syringe to relieve pain induced by osteoarthritis.... -
Product OSTENIL® Plus
OSTENIL® PLUS is a unique combination of natural high dose HA (2%) + mannitol.
The formulation offers the possibility of reducing the number of intra-articular injections and increasing the intervals between injections. OSTENIL® PLUS: pre-filled syringe to relieve pain induced by ...
TRB Chemedica International SA resources (3)
-
Brochure TRB SWISS MANUFACTURING PLANT
Presentation of TRB Swiss plant based in Vouvry. -
Brochure Vismed Range hyaluronic acid for all your needs
Presentation of the Vismed range for dry eye from TRB Chemedica -
Brochure Diacerein, Oral inhibition of interleukin-1 in the treatment of osteoarthritis
DIACEREIN is indicated for the specific, long-term oral treatment of degenerative joint diseases (osteoarthritis and related diseases). DIACEREIN has a unique mode of action through inhibition of the production and activity of interleukin-1, the key mediator in the progression of osteoarthritis.









